11,665 SPDR S&P Biotech ETF $XBI Shares Sold by Sonata Capital Group Inc.

Sonata Capital Group Inc. decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 85.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,925 shares of the exchange traded fund’s stock after selling 11,665 shares during the period. Sonata Capital Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $304,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of XBI. Cornell Pochily Investment Advisors Inc. raised its stake in SPDR S&P Biotech ETF by 21.9% during the third quarter. Cornell Pochily Investment Advisors Inc. now owns 1,919 shares of the exchange traded fund’s stock worth $303,000 after acquiring an additional 345 shares in the last quarter. IFP Advisors Inc boosted its stake in shares of SPDR S&P Biotech ETF by 4.7% in the 3rd quarter. IFP Advisors Inc now owns 22,189 shares of the exchange traded fund’s stock valued at $3,499,000 after purchasing an additional 997 shares in the last quarter. Robertson Stephens Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 0.5% in the 3rd quarter. Robertson Stephens Wealth Management LLC now owns 21,640 shares of the exchange traded fund’s stock valued at $3,412,000 after purchasing an additional 99 shares in the last quarter. Guardian Asset Advisors LLC boosted its stake in shares of SPDR S&P Biotech ETF by 34.1% in the 3rd quarter. Guardian Asset Advisors LLC now owns 1,850 shares of the exchange traded fund’s stock valued at $292,000 after purchasing an additional 470 shares in the last quarter. Finally, Sweeney & Michel LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $204,000.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock traded up $3.52 during midday trading on Monday, hitting $147.84. 5,218,316 shares of the company traded hands, compared to its average volume of 9,164,976. The stock has a market cap of $10.21 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. The firm’s fifty day moving average price is $158.09 and its 200-day moving average price is $147.07. SPDR S&P Biotech ETF has a 12 month low of $106.30 and a 12 month high of $169.89.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.